A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

NCT01236235 ·Status: COMPLETED

Atazanavir for HIV Infected Individuals: An Early Access Program

NCT00046345 ·Status: NO_LONGER_AVAILABLE

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

NCT00357188 ·Status: COMPLETED ·Phase: PHASE1

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

NCT00814879 ·Status: COMPLETED ·Phase: NA

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

NCT01803074 ·Status: COMPLETED ·Phase: PHASE2

A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy Adults

NCT05538312 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

NCT01705574 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

NCT01620944 ·Status: TERMINATED ·Phase: PHASE3

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen

NCT00135343 ·Status: COMPLETED ·Phase: PHASE3

A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia

NCT02542852 ·Status: COMPLETED ·Phase: PHASE2

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

NCT00207142 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

NCT00035932 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

NCT00028067 ·Status: TERMINATED ·Phase: PHASE3

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

NCT00054717 ·Status: COMPLETED ·Phase: PHASE3

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393 ·Status: COMPLETED ·Phase: PHASE3

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

NCT00384904 ·Status: COMPLETED ·Phase: PHASE4

B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

NCT03532425 ·Status: TERMINATED ·Phase: PHASE4

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

NCT00144833 ·Status: TERMINATED ·Phase: PHASE3

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

NCT00357552 ·Status: COMPLETED ·Phase: NA

Atazanavir Twice Daily

NCT00357721 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

NCT01225705 ·Status: WITHDRAWN ·Phase: PHASE4

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants

NCT00833482 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

NCT00122577 ·Status: TERMINATED ·Phase: PHASE2

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

NCT00326716 ·Status: COMPLETED ·Phase: PHASE1